Medicine and Dentistry
Colorectal Carcinoma
84%
Neoplasm
75%
Abdominal Cancer
53%
Gastrectomy
52%
Postoperative Complication
51%
Surgery
39%
Esophagectomy
35%
Quality of Life
34%
Cohort Analysis
33%
Diagnosis
30%
Rectum Cancer
30%
Retrospective Cohort Study
28%
Elderly Patient
28%
Chronic Pancreatitis
28%
Computer Assisted Tomography
27%
Pancreas Cancer
27%
Intraductal Papillary Mucinous Tumor
24%
Coeliac Disease
24%
Randomized Clinical Trial
24%
Diverticulitis
24%
Ileostomy
24%
Rectum Resection
24%
Hazard Ratio
23%
Diseases
22%
Overall Survival
22%
Recurrent Disease
22%
Stomach Adenocarcinoma
20%
Malignant Neoplasm
20%
Cholecystectomy
20%
Anastomosis Leakage
20%
Cancer Surgery
19%
Prognostic Factor
19%
Laparoscopic Cholecystectomy
19%
Incisional Hernia
18%
Comorbidity
18%
Stroma
17%
Symptomatic Treatment
16%
Urokinase Receptor
16%
Lung Metastasis
16%
Esophageal Cancer
16%
Dysplasia
16%
Antibiotics
15%
Neoadjuvant Therapy
15%
Prevalence
15%
Total Stomach Resection
14%
Immunocompetent Cell
14%
Odds Ratio
13%
Bleeding
13%
Surgical Infection
12%
Reoperation
12%
Immunity
12%
Stoma
12%
Programmed Death-Ligand 1
12%
Immunotherapy
12%
Placebo
12%
Cell Density
11%
CD3 Antigen
11%
Patient Referral
11%
Stenting
11%
Esophageal Stent
11%
Endoscopic Retrograde Cholangiopancreatography
11%
Acute Cholecystitis
10%
Cholangitis
10%
Serositis
10%
Acute Pancreatitis
10%
Osteoporosis
10%
Pancreatic Surgery
10%
Surgical Anastomosis
10%
Indoleamine 2,3 Dioxygenase
10%
Hernia
10%
T Cell
9%
Cellular Infiltration
9%
Recurrence Risk
9%
CD8 Antigen
9%
Disease Severity
9%
Circulating Tumor DNA
9%
Sarcopenia
9%
Esophageal Cancer
9%
Psoas Muscle
9%
Colostomy
9%
Vedolizumab
9%
DNA Mismatch Repair
9%
Scoring System
9%
Exocrine Pancreatic Insufficiency
9%
Adipose Tissue
8%
Tumor Cell
8%
Adverse Event
8%
Partial Gastrectomy
8%
Pancreatic Injury
8%
Fecal Microbiota Transplantation
8%
Immune Cell Infiltration
8%
Chronic Fatigue Syndrome
8%
Prospective Study
8%
Upper Gastrointestinal Bleeding
8%
Protein Glutamine Gamma Glutamyltransferase Antibody
8%
Retrospective Study
8%
Antibiotic Therapy
8%
Protein Glutamine Gamma Glutamyltransferase 2
8%
Radiofrequency Ablation
8%
Mucus
8%
Keyphrases
Finland
100%
Colorectal Cancer
76%
Gastric Cancer
45%
Postoperative Complications
44%
Gastrectomy
43%
Population-based
43%
Population-based Study
39%
Celiac Disease
35%
Randomized Clinical Trial
32%
Retrospective Cohort Study
29%
Elderly Patients
28%
Chronic Pancreatitis
28%
Computed Tomography
25%
Acute Diverticulitis
24%
Tumor
23%
After Surgery
23%
Anastomotic Leak
21%
Quality of Life
21%
Tertiary Care Hospital
20%
Confidence Interval
20%
Gastric Adenocarcinoma
20%
Overall Survival
20%
Cholecystectomy
19%
Laparoscopic Cholecystectomy
19%
Pancreatic Cancer
18%
Total Gastrectomy
18%
Incisional Hernia
18%
Hazard Ratio
18%
Esophageal Cancer
17%
Surgical Site Infection
16%
Europe
16%
Intraductal Papillary mucinous Neoplasm
16%
Biological Mesh
16%
Synthetic Mesh
16%
Loop Ileostomy Closure
16%
Inflammatory Bowel Disease
16%
Rectal Resection
16%
Oral Antibiotics
16%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
16%
Pulmonary Metastasis
16%
Transglutaminase 2 Inhibitor
16%
Post-esophagectomy
16%
Prognostic Role
16%
Non-associated
15%
Endoscopic Surgery
15%
Comorbidity
15%
Oncological Outcomes
15%
Tissue Transglutaminase Antibodies
14%
Esophagectomy
14%
Prognostic Factors
14%
Obesity
13%
Surgical Outcomes
13%
National Cohort Study
13%
Pancreatic Ductal Adenocarcinoma
13%
University Hospital
13%
High Risk
12%
5-year Survival
12%
90-day Mortality
12%
Risk Factors
11%
Gastrointestinal
11%
Neoadjuvant Therapy
11%
Odds Ratio
11%
Multicenter Cohort Study
11%
Pancreatic Cyst
11%
Exocrine Pancreatic Insufficiency
11%
Resection
11%
Indoleamine 2,3-dioxygenase 1 (IDO1)
10%
Acute Cholecystitis
10%
Pancreatic Surgery
10%
Osteoporosis
10%
Cell-to-cell
10%
Esophageal Stent
10%
Cell Density
10%
Lynch Syndrome
10%
Carbohydrate Antigen 19-9 (CA19-9)
10%
Nordic Countries
10%
Esophageal Complications
10%
Consensus Group
10%
Retrorectus
9%
Distal Gastrectomy
9%
Disease Severity
9%
Gastric Cancer Surgery
9%
Complicated Acute Diverticulitis
9%
Reoperation
9%
Absence of Evidence
9%
Sarcopenia
9%
Multicenter Trial
9%
Robotic-assisted
9%
Incidence Trends
9%
Cancer Microenvironment
9%
Immune Cell Score
9%
Placebo-controlled
9%
Intravenous Antibiotics
9%
Gluten
9%
Consecutive Patients
9%
Vedolizumab
9%
Clinical Characteristics
9%
Tumor Budding
9%
Improved Survival
9%
Physical Activity
9%